CCMD-3

Based on the diagnostic criteria of organic mental disorder in CCMD-3 , mental disorders in 255 subjects were diagnosed .

依据CCMD-3诊断标准中有关器质性精神障碍的分类进行精神障碍的诊断。

There was corresponding relationship between UPI and CCMD-3 .

UPI抑郁症症状检测与CCMD-3抑郁症状诊断有对应关系。

Field Trial Of the Revised Criteria of Mental Disorders usually first Diagnosed in Infancy , Childhood or Adolescence in CCMD-3

中国精神疾病分类与诊断标准第三版（CCMD-3）儿童青少年部分的修订与现场测试

Methods 30 in-patients who met the criteria for paranoid schizophrenia in the CCMD-3 were randomly selected as research group and 20 healthy volunteers as control group .

方法随机选取30例住院患者为实验组，均符合《中国精神障碍分类与诊断标准》第3版精神分裂症偏执型诊断标准，入组后单用氯氮平治疗；选取20例健康志愿者作为对照组。

Met the diagnostic standards of developmental disorder for special school skills in the third edition of the Chinese Classification and diagnostic criteria of Mental Disorders ( CCMD-3 );

符合中国精神障碍分类与诊断标准&特定学校技能发育障碍的诊断标准。

Methods 17 patients from 36 months to 8 years old diagnosed autism according to CCMD-3 were given oral olanzapine 2.5 ~ 10 mg per day for 12 weeks .

方法用奥氮平对17例1岁半～8岁符合CCMD-3诊断的孤独症患者进行治疗，剂量为2.5～10mg/d，连续用药并观察12周。

Method : The researchers exam with EMBU 195 schizophrenic inpatients who accord with CCMD-3 criteria of schizophrenia and are in stable mental condition .

方法：本研究采用父母教养方式量表（EMBU）对195例符合CCMD-3标准、病情基本缓解的住院精神分裂症患者进行了评估。

Methods : 214 inpatients with diagnosis of schizophrenia by CCMD-3 were investigated for going-home desire and assessed with PANSS and GAS .

方法：对214名分裂症患者进行回家意愿、愿因及精神症状调查，并分组给予PANSS量表、GAS量表的测定。

Diagnosis of depression according to the Chinese Classification and Diagnostic Criteria of Mental Disorders CCMD-3 criteria , divided into the depression group and the non-depressed group . 5 .

抑郁诊断根据中国精神障碍分类与诊断标准CCMD-3的标准，将其分为抑郁组和非抑郁组。

Conclusion CCMD-3 has admited and formulated the diagnosis standard of somatoform disorders and it can increase the rate of patients ' diagnosis and can decrease patients ' cost .

结论CCMD-3已经承认和制订了躯体形式障碍的诊断标准，它可以提高病人的诊断和治愈率，并减少病人的经济支出。

Method : 72 patients with post-stroke depression met the criteria of CCMD-3 for organic mental disorder were assigned randomly to citalopram group or amitriptyline group for eight weeks .

方法：72例脑卒中后抑郁患者，随机分成两组，分别用西酞普兰和阿米替林治疗8周。

Our experimental group collected 13 cases of schizophrenia brain tissue by autopsy , which were diagnosed schizophrenia by CCMD-3 criteria for clinical ( 7 males , 6 females ) .

本实验组通过尸体解剖收集了临床CCMD-3标准诊断为精神分裂症的脑组织标本13例（其中男性7例，女性6例）。

Methods : 44 patients who met with CCMD-3 criteria for somatization disorder and92 depression patients without somatic symptoms were assessed with HAMD , SDS and SCL-90 .

方法：选取44例符合CCMD-3躯体化障碍诊断标准的患者（研究组）和92例不伴躯体症状的抑郁症患者（对照组），分别用HAMD、SDS、SCL-90进行评定。

Methods Marking analysis of the62 patients in our hospital who chiefly complain the body symptoms according to CCMD-3 a standard and trying to find out the cause of the mistreament .

方法按照CCMD-3诊断标准，对我院门诊62例以躯体化症状为主诉的精神病人的既往误诊情况进行分析，并探讨误诊原因。

Methods : All patients who met the criteria of CCMD-3 about GAD were randomly assigned Sertraline plus Wu ling Capsule ( observation group ) and Zoloft ( control group ) .

方法：入组对象均符合《中国精神疾病分类与诊断标准-3》（CCMD-3）GAD的诊断标准，随机分左洛复合用乌灵胶囊组（观察组）和左洛复组（对照组）。

Method 65 cases were collected from assessed data during 2002 / 1-2003 / 6 , the clinical symptoms was classified by CCMD-3 , the type of cerebral injury , assessment time and conclusion were retrospectively and statistically analyzed .

方法回溯即往一年半的鉴定资料，根据CCMD-3器质性精神障碍的症状分类对被鉴定人临床表现进行整理归纳，整理被鉴定人颅脑受伤的类型，统计分析评定时机及评定结论。

All the patients signed the agreement , and they were accordance with the diagnosis criteria of CCMD-3 depression . No significant difference was found in the baseline data such as sex , age and course of disease ( P > 0.05 ) .

两组患者均签署知情同意书，符合CCMD-3抑郁症的诊断标准，性别、年龄、病程等基线资料基本相似（P>0.05）。

Methods 120 patients in community who were in accordance with schizophrenia of CCMD-3 were evaluated with HAMD , BPRS , SAPS , SANS , LES and TESS . The data and the related factors were analyzed .

方法对符合CCMD-3诊断标准的社区精神分裂症患者120例进行HAMD、BPRS、SAPS、SANS、LES、TESS等量表的评定及其相关分析。

Methods : 17 patients meeting the criterion of CCMD-3 and ICD-10 for schizophrenia were assessed psychotic symptoms with the rating scale of PANSS and valued cognitive functions by 9 neuropsychological tests and checked Neurological Soft Signs ( NSS ) .

方法：对17例符合CCMD-3和ICD-10中精神分裂症诊断标准的患者采用PANSS进行精神症状评定；

Methods : The 68 patients meeting criteria of manic episode or schizoaffective disorder in CCMD-3 were randomly divided into studying group ( combination of quetiapine and lithium or valproate ) and control group ( single using of lithium or valproate ) and observed for 6 weeks .

方法将符合CCMD-3躁狂发作或分裂情感障碍诊断标准的68例研究对象随机分成两组，研究组应用奎硫平合并碳酸锂或丙戊酸钠，对照组单一使用碳酸锂或丙戊酸钠，治疗观察6周。